LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Third Quarter 2019 Financial Results
October 10, 2019 16:10 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results
February 07, 2019 16:05 ET | Fluidigm Corporation
Fourth quarter revenue increased 17 percent to $32.3 million Mass cytometry revenue growth of 48 percent in fourth quarter Full year 2018 revenue increased 11 percent to $113.0 millionIncluding...
LogoPressRelease.jpg
Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1
January 31, 2019 08:30 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, today announced the introduction of a...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results
January 14, 2019 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report...
LogoPressRelease.jpg
Fluidigm to Participate in the 30th Annual Piper Jaffray Healthcare Conference
November 12, 2018 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s...
LogoPressRelease.jpg
Fluidigm Announces Third Quarter 2018 Financial Results
November 01, 2018 16:05 ET | Fluidigm Corporation
Total revenue increases 17 percent to $29.0 million Mass cytometry revenue growth of 50 percent Instrument revenue growth of 32 percent SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results
October 01, 2018 16:15 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report...
LogoPressRelease.jpg
Fluidigm Introduces Single-Cell Total RNA Sequencing Applications for C1
September 27, 2018 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced two new total RNA sequencing...
LogoPressRelease.jpg
Fluidigm Introduces a Lower-Cost Workflow for Full-Length Single-Cell mRNA Sequencing on C1
July 31, 2018 08:30 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new full-length single-cell mRNA...
LogoPressRelease.jpg
Fluidigm Announces First Multimodal Single-Cell Application for the C1
July 10, 2018 08:30 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new bimodal single‑cell application...